With increasing demand for efficient drug delivery systems, especially for injectable drug delivery, the need for innovative injectable drug delivery options has risen. Given the advantages of standalone drug injecting systems such as prefilled syringes, such as ease in use and enhanced safety, their demand is expected to increase at a high pace in the coming years.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=603

According to Fact.MR analysis on prefilled syringes, the global market for prefilled syringes is anticipated to expand at a meteoric rate during the period of forecast. The global prefilled syringes market is poised to grow at a volume CAGR of 9.1% during the period of assessment, 2017-2026 and the sale of prefilled syringes across the globe is estimated to cross US$ 11 Bn by end of the year of assessment (2026).

Manufacturers are focused on developing enhanced prefilled syringe systems to cater to the growing demand for these injectable drug delivery systems. For instance, Becton Dickinson has developed PosiFlush prefilled syringes with a 4% sodium citrate lock solution that can reduce the number of catheters for hemodialysis by about exchanged per 1000 days by about 59% thus minimizing risks.

The research report on global prefilled syringes market has profiled many such key companies involved in the manufacturing of prefilled syringes, such as Unilife Corporation, Sterinova, SHL Group, NIPRO, Bespak, AptarGroup, West Pharmaceutical Services Inc., Vetter Pharma International GmbH, Stevanato Group, SCHOTT AG, Gerresheimer, Medtronic, Baxter International Inc., Terumo Medical Corporation and Becton Dickinson and Company.

Get the Discount on the Report: https://www.factmr.com/connectus/sample?flag=D&rep_id=603

North America in terms of sale of prefilled syringes tops other regional market during the period of assessment. This regions, especially dominated by United States, has witnessed increased adoption of glass prefilled syringes owing to high presence of chronic disorders. On the other hand, Asia Pacific excluding Japan (APEJ) region is expected to showcase increased inclination towards these injectable drug delivery systems. Asia Pacific excluding Japan region has shown immense potential as a favorable market place for various end use industries owing to its huge business potential. This has increased the presence of various pharmaceutical industries in the region. Moreover, increasing population growth in China and India, along with aging population has raised the demand bar for prefilled syringes to inject drugs to treat diseases such as diabetes and other autoimmune disorders.

By material type, glass based prefilled syringes hold the highest market share and sales of glass based prefilled syringes is estimated to surpass U$ 7.5 Bn by end of 2026. However, owing to high fragile nature of these syringes, manufacturers have developed polymer based prefilled syringes that are also gaining high traction. Polymer based prefilled syringes have a comparatively higher break resistance and do not react with the drug they carry.

With respect to distribution channels, hospitals are the most lucrative. Sale of both glass and polymer based prefilled syringes from hospitals is estimated to reach a value of over US$ 6.5 Bn by end of the year of assessment. Online pharmacies and specialty clinics are also expected to significantly contribute to the growth of the global prefilled syringes market in the coming years.

Ask for the Country Specific Data: https://www.factmr.com/connectus/sample?flag=AFCD&rep_id=603

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Tel: +353-1-6111-593
Email: [email protected]
Blog: https://theheraldmedia.com/